We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+6.25%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$17.4B
AUM Growth
+$904M
Cap. Flow
+$84.9M
Cap. Flow %
0.49%
Top 10 Hldgs %
29.78%
Holding
722
New
36
Increased
329
Reduced
218
Closed
40

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$66.4M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$57.7M
3
AMZN icon
Amazon
AMZN
+$56.5M
4
AMD icon
Advanced Micro Devices
AMD
+$37.5M
5
CRM icon
Salesforce
CRM
+$35.5M

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$122M
2
TMO icon
Thermo Fisher Scientific
TMO
+$60.8M
3
AMAT icon
Applied Materials
AMAT
+$43.7M
4
NU icon
Nu Holdings
NU
+$35.9M
5
INCY icon
Incyte
INCY
+$32.5M

Sector Composition

Rank Sector Weight
1 Technology 31.8%
2 Healthcare 28.54%
3 Financials 9.44%
4 Consumer Discretionary 7.84%
5 Industrials 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XYL icon
51
Xylem
XYL
$28.7B
$73.1M 0.42%
541,033
+236,871
+78% +$31.7M
PEP icon
52
PepsiCo
PEP
$191B
$72.8M 0.42%
428,219
+16,275
+4% +$2.8M
ADSK icon
53
Autodesk
ADSK
$47.7B
$72.7M 0.42%
263,948
+125,964
+91% +$31.7M
WAB icon
54
Wabtec
WAB
$50.7B
$70.3M 0.4%
386,571
+198,384
+105% +$32.5M
ALTR
55
DELISTED
Altair Engineering Inc
ALTR
$66.9M 0.38%
700,698
+140,133
+25% +$12.7M
TJX icon
56
TJX Companies
TJX
$173B
$65.9M 0.38%
560,897
+20,518
+4% +$2.35M
BKNG icon
57
Booking.com
BKNG
$145B
$65.5M 0.38%
388,500
-120,675
-24% -$18.5M
TRMB icon
58
Trimble
TRMB
$13B
$64.7M 0.37%
1,042,214
-75,211
-7% -$4.2M
CTAS icon
59
Cintas
CTAS
$84.3B
$64.7M 0.37%
314,255
-29,133
-8% -$5.62M
SPGI icon
60
S&P Global
SPGI
$131B
$64.6M 0.37%
125,121
+4,636
+4% +$2.29M
VEEV icon
61
Veeva Systems
VEEV
$31.6B
$63.4M 0.36%
302,269
+10,061
+3% +$1.99M
TTEK icon
62
Tetra Tech
TTEK
$8.28B
$62.8M 0.36%
1,332,593
-61,732
-4% -$2.75M
NEE icon
63
NextEra Energy
NEE
$185B
$62.5M 0.36%
739,448
+72,775
+11% +$5.68M
BAC icon
64
Bank of America
BAC
$436B
$59.6M 0.34%
1,502,117
+32,860
+2% +$1.32M
ELV icon
65
Elevance Health
ELV
$82B
$58.7M 0.34%
112,933
-3,267
-3% -$1.75M
NBIX icon
66
Neurocrine Biosciences
NBIX
$17.8B
$55.7M 0.32%
483,241
+17,774
+4% +$2.44M
MRVL icon
67
Marvell Technology
MRVL
$169B
$55.4M 0.32%
767,716
+52,196
+7% +$3.61M
NU icon
68
Nu Holdings
NU
$70.2B
$54.6M 0.31%
4,001,429
-2,667,571
-40% -$35.9M
INCY icon
69
Incyte
INCY
$23.8B
$53.5M 0.31%
809,733
-509,948
-39% -$32.5M
CRWD icon
70
CrowdStrike
CRWD
$184B
$53.4M 0.31%
761,844
-89,668
-11% -$6.37M
MS icon
71
Morgan Stanley
MS
$336B
$53M 0.3%
508,289
+114,448
+29% +$11.5M
CMCSA icon
72
Comcast
CMCSA
$81.6B
$52.7M 0.3%
1,262,615
-166,405
-12% -$6.57M
BNY
73
Bank of New York Mellon
BNY
$107B
$51.6M 0.3%
717,995
-223,214
-24% -$14.7M
BDX icon
74
Becton Dickinson
BDX
$44B
$51.2M 0.29%
212,410
-28,607
-12% -$6.7M
NKE icon
75
Nike
NKE
$62.4B
$48.7M 0.28%
551,291
+121,083
+28% +$9.5M
1 2
3
4 5

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2024 Portfolio in Review

As of Q3 2024, Candriam SCA held 722 positions worth $17.4B, up 5.5% from $16.5B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Candriam SCA's Q3 2024 filing shows 36 new, 329 increased, 218 reduced and 40 closed positions. Its largest new stake was Avidity Biosciences: 323,396 shares worth $14.9M. The largest sale was Lam Research, an estimated $122M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q3 2024 buy was Avidity Biosciences: 323,396 shares worth $14.9M.
  • Candriam SCA added most to Amgen in Q3 2024, an estimated $66.4M increase.
  • Candriam SCA's biggest Q3 2024 reduction was Thermo Fisher Scientific, cutting an estimated $60.8M.
  • Candriam SCA fully exited Lam Research in Q3 2024, selling an estimated $122M.
  • Candriam SCA's ten largest holdings make up 30% of its $17.4B portfolio in Q3 2024.
  • Candriam SCA opened 36 new positions and closed 40 in Q3 2024.
  • Candriam SCA's portfolio value rose 5.5% quarter-over-quarter to $17.4B.

Based on Candriam SCA's 13F filing for Q3 2024, filed 13 Nov 2024.